Atlas Trials

The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia

Clinical trial NCT07151612 · COMPLETED

Trial details

NCT number
NCT07151612
Sponsor
Shanxi Eye Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Presbyopia
Start date
2025-09-04
Primary completion
2025-10-08
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.